Global And United States Aneurysmal Subarachnoid Hemorrhage Drugs Market Insights, Forecast To 2027

1 Study Coverage
1.1 Aneurysmal Subarachnoid Hemorrhage Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Type
1.2.2 Opioid Analgesic
1.2.3 Calcium Channel Blocker
1.2.4 Anticonvulsant
1.2.5 Stool Softener
1.2.6 Osmotic Agent
1.2.7 Other Drugs
1.3 Market by Application
1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, Estimates and Forecasts
2.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue 2016-2027
2.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales 2016-2027
2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Aneurysmal Subarachnoid Hemorrhage Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Aneurysmal Subarachnoid Hemorrhage Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Region (2022-2027)

3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Competitor Landscape by Players
3.1 Global Top Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers by Sales
3.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers by Revenue
3.2.1 Key Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Aneurysmal Subarachnoid Hemorrhage Drugs Revenue in 2020
3.2.6 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Manufacturers
3.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturing Base Distribution, Product Types
3.4.1 Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Aneurysmal Subarachnoid Hemorrhage Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type (2016-2021)
4.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2016-2021)
4.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2016-2021)
4.1.3 Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application (2016-2021)
5.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2016-2021)
5.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2016-2021)
5.1.3 Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2016-2021)
5.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Aneurysmal Subarachnoid Hemorrhage Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales YoY Growth 2016-2027
6.1.2 United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Aneurysmal Subarachnoid Hemorrhage Drugs Market Share in Global Market 2016-2027
6.2 United States Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Aneurysmal Subarachnoid Hemorrhage Drugs Players by Sales (2016-2021)
6.2.2 United States Top Aneurysmal Subarachnoid Hemorrhage Drugs Players by Revenue (2016-2021)
6.3 United States Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2016-2021)
6.4 United States Aneurysmal Subarachnoid Hemorrhage Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Aneurysmal Subarachnoid Hemorrhage Drugs Price Forecast by Type (2022-2027)
6.5 United States Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2016-2021)
6.6 United States Aneurysmal Subarachnoid Hemorrhage Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Aneurysmal Subarachnoid Hemorrhage Drugs Price Forecast by Application (2022-2027)

7 North America
7.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size YoY Growth 2016-2027
7.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
7.2.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021)
7.2.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Size YoY Growth 2016-2027
9.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
9.2.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021)
9.2.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
10.2.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021)
10.2.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Arbor Pharmaceuticals
12.1.1 Arbor Pharmaceuticals Corporation Information
12.1.2 Arbor Pharmaceuticals Description and Business Overview
12.1.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.1.5 Arbor Pharmaceuticals Recent Development
12.2 PDS Biotechnology Corporation
12.2.1 PDS Biotechnology Corporation Corporation Information
12.2.2 PDS Biotechnology Corporation Description and Business Overview
12.2.3 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.2.5 PDS Biotechnology Corporation Recent Development
12.3 Johnson and Johnson
12.3.1 Johnson and Johnson Corporation Information
12.3.2 Johnson and Johnson Description and Business Overview
12.3.3 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.3.5 Johnson and Johnson Recent Development
12.4 Mylan N.V
12.4.1 Mylan N.V Corporation Information
12.4.2 Mylan N.V Description and Business Overview
12.4.3 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.4.5 Mylan N.V Recent Development
12.5 Orexo AB
12.5.1 Orexo AB Corporation Information
12.5.2 Orexo AB Description and Business Overview
12.5.3 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.5.5 Orexo AB Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.6.5 Pfizer Recent Development
12.7 Purdue Pharma
12.7.1 Purdue Pharma Corporation Information
12.7.2 Purdue Pharma Description and Business Overview
12.7.3 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.7.5 Purdue Pharma Recent Development
12.8 Pharmaxis
12.8.1 Pharmaxis Corporation Information
12.8.2 Pharmaxis Description and Business Overview
12.8.3 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.8.5 Pharmaxis Recent Development
12.9 Sun Pharmaceutical Industries
12.9.1 Sun Pharmaceutical Industries Corporation Information
12.9.2 Sun Pharmaceutical Industries Description and Business Overview
12.9.3 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.9.5 Sun Pharmaceutical Industries Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Corporation Information
12.10.2 Teva Pharmaceutical Description and Business Overview
12.10.3 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.10.5 Teva Pharmaceutical Recent Development
12.11 Arbor Pharmaceuticals
12.11.1 Arbor Pharmaceuticals Corporation Information
12.11.2 Arbor Pharmaceuticals Description and Business Overview
12.11.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
12.11.5 Arbor Pharmaceuticals Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Trends
13.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Drivers
13.3 Aneurysmal Subarachnoid Hemorrhage Drugs Market Challenges
13.4 Aneurysmal Subarachnoid Hemorrhage Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Aneurysmal Subarachnoid Hemorrhage Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Opioid Analgesic
Table 3. Major Manufacturers of Calcium Channel Blocker
Table 4. Major Manufacturers of Anticonvulsant
Table 5. Major Manufacturers of Stool Softener
Table 6. Major Manufacturers of Osmotic Agent
Table 7. Major Manufacturers of Other Drugs
Table 8. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 9. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Regions (2016-2021) & (K MT)
Table 11. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions (2016-2021)
Table 12. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 14. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturers (2016-2021) (K MT)
Table 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 20. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Manufacturers (2016-2021)
Table 22. Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Aneurysmal Subarachnoid Hemorrhage Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs as of 2020)
Table 24. Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Price (2016-2021) (USD/MT)
Table 25. Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Type
Table 27. Date of International Manufacturers Enter into Aneurysmal Subarachnoid Hemorrhage Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2016-2021) (K MT)
Table 30. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2016-2021)
Table 31. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2016-2021)
Table 33. Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 34. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 35. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 39. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2016-2021) (K MT)
Table 40. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2016-2021)
Table 41. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2016-2021)
Table 43. Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 44. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 45. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 49. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) of Key Companies (2016-2021)
Table 50. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Company (2016-2021)
Table 51. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) by Company (2016-2021)
Table 52. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Company (2016-2021)
Table 53. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2016-2021)
Table 54. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2016-2021)
Table 55. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. United States Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Type (2016-2021)
Table 57. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2022-2027)
Table 58. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2022-2027)
Table 59. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2022-2027)
Table 61. United States Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Type (2022-2027)
Table 62. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Application (2016-2021)
Table 63. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2016-2021)
Table 64. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. United States Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Application (2016-2021)
Table 66. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Application (2022-2027)
Table 67. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2022-2027)
Table 68. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2022-2027)
Table 70. United States Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT) by Application (2022-2027)
Table 71. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021) & (K MT)
Table 72. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2016-2021)
Table 73. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2016-2021) & (K MT)
Table 76. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2016-2021)
Table 79. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021) & (K MT)
Table 80. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2016-2021)
Table 81. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2016-2021)
Table 83. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021) & (K MT)
Table 84. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2016-2021) & (K MT)
Table 88. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country (2016-2021)
Table 91. Arbor Pharmaceuticals Corporation Information
Table 92. Arbor Pharmaceuticals Description and Business Overview
Table 93. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 94. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 95. Arbor Pharmaceuticals Recent Development
Table 96. PDS Biotechnology Corporation Corporation Information
Table 97. PDS Biotechnology Corporation Description and Business Overview
Table 98. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 99. PDS Biotechnology Corporation Product
Table 100. PDS Biotechnology Corporation Recent Development
Table 101. Johnson and Johnson Corporation Information
Table 102. Johnson and Johnson Description and Business Overview
Table 103. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 104. Johnson and Johnson Product
Table 105. Johnson and Johnson Recent Development
Table 106. Mylan N.V Corporation Information
Table 107. Mylan N.V Description and Business Overview
Table 108. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 109. Mylan N.V Product
Table 110. Mylan N.V Recent Development
Table 111. Orexo AB Corporation Information
Table 112. Orexo AB Description and Business Overview
Table 113. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 114. Orexo AB Product
Table 115. Orexo AB Recent Development
Table 116. Pfizer Corporation Information
Table 117. Pfizer Description and Business Overview
Table 118. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 119. Pfizer Product
Table 120. Pfizer Recent Development
Table 121. Purdue Pharma Corporation Information
Table 122. Purdue Pharma Description and Business Overview
Table 123. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 124. Purdue Pharma Product
Table 125. Purdue Pharma Recent Development
Table 126. Pharmaxis Corporation Information
Table 127. Pharmaxis Description and Business Overview
Table 128. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 129. Pharmaxis Product
Table 130. Pharmaxis Recent Development
Table 131. Sun Pharmaceutical Industries Corporation Information
Table 132. Sun Pharmaceutical Industries Description and Business Overview
Table 133. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 134. Sun Pharmaceutical Industries Product
Table 135. Sun Pharmaceutical Industries Recent Development
Table 136. Teva Pharmaceutical Corporation Information
Table 137. Teva Pharmaceutical Description and Business Overview
Table 138. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 139. Teva Pharmaceutical Product
Table 140. Teva Pharmaceutical Recent Development
Table 141. Aneurysmal Subarachnoid Hemorrhage Drugs Market Trends
Table 142. Aneurysmal Subarachnoid Hemorrhage Drugs Market Drivers
Table 143. Aneurysmal Subarachnoid Hemorrhage Drugs Market Challenges
Table 144. Aneurysmal Subarachnoid Hemorrhage Drugs Market Restraints
Table 145. Aneurysmal Subarachnoid Hemorrhage Drugs Customers List
Table 146. Aneurysmal Subarachnoid Hemorrhage Drugs Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Aneurysmal Subarachnoid Hemorrhage Drugs Product Picture
Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Opioid Analgesic Product Picture
Figure 4. Calcium Channel Blocker Product Picture
Figure 5. Anticonvulsant Product Picture
Figure 6. Stool Softener Product Picture
Figure 7. Osmotic Agent Product Picture
Figure 8. Other Drugs Product Picture
Figure 9. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Aneurysmal Subarachnoid Hemorrhage Drugs Report Years Considered
Figure 14. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size 2016-2027 (US$ Million)
Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales 2016-2027 (K MT)
Figure 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2016-2021)
Figure 19. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region in 2020
Figure 20. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2016-2021)
Figure 21. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region in 2020
Figure 22. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Aneurysmal Subarachnoid Hemorrhage Drugs Revenue in 2020
Figure 24. Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2016-2021)
Figure 26. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type in 2020
Figure 27. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2016-2021)
Figure 28. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type in 2020
Figure 29. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2016-2021)
Figure 30. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application in 2020
Figure 31. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2016-2021)
Figure 32. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application in 2020
Figure 33. United States Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate 2016-2027 (K MT)
Figure 34. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. United States Aneurysmal Subarachnoid Hemorrhage Drugs Market Share in Global Market 2016-2027
Figure 36. United States 5 and 10 Largest Aneurysmal Subarachnoid Hemorrhage Drugs Players Market Share by Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs in 2020
Figure 37. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2016-2021)
Figure 38. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 39. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2016-2021)
Figure 40. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 42. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country in 2020
Figure 44. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country in 2020
Figure 45. U.S. Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 46. U.S. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 48. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 50. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country in 2020
Figure 52. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country in 2020
Figure 53. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 54. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 56. France Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 58. U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 60. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 62. Russia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 64. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region in 2020
Figure 66. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region in 2020
Figure 67. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 68. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 70. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 72. South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 74. India Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 76. Australia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 78. Taiwan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 80. Indonesia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 82. Thailand Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 84. Malaysia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 86. Philippines Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 88. Vietnam Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 90. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country in 2020
Figure 92. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country in 2020
Figure 93. Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 94. Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 96. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 98. Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 100. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Country in 2020
Figure 103. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 104. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 106. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. U.A.E Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 108. U.A.E Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Aneurysmal Subarachnoid Hemorrhage Drugs Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.